Introduction: It is known that warfarin treatment is problematic, due to its narrow therapeutic range and to the great interindividual variability. Numerous papers have shown the important contribution of CYP2C9 and VKORC1 genetic variants to this variability. Recently, a new SNP within the CYP4F2 gene was found associated with warfarin dose in the USA.
Borgiani, P., Ciccacci, C., Forte, V., Sirianni, E., Novelli, L., Bramanti, P., et al. (2009). CYP4F2 genetic variant (rs2108622) significantly contributes to warfarin dosing variability in the Italian population. PHARMACOGENOMICS, 10(2), 261-266 [10.2217/14622416.10.2.261].
Tipologia: | Articolo su rivista | |
Citazione: | Borgiani, P., Ciccacci, C., Forte, V., Sirianni, E., Novelli, L., Bramanti, P., et al. (2009). CYP4F2 genetic variant (rs2108622) significantly contributes to warfarin dosing variability in the Italian population. PHARMACOGENOMICS, 10(2), 261-266 [10.2217/14622416.10.2.261]. | |
IF: | Con Impact Factor ISI | |
Lingua: | English | |
Settore Scientifico Disciplinare: | Settore MED/03 - Genetica Medica | |
Revisione (peer review): | Sì, ma tipo non specificato | |
Tipo: | Articolo | |
Rilevanza: | Rilevanza internazionale | |
Digital Object Identifier (DOI): | http://dx.doi.org/10.2217/14622416.10.2.261 | |
Stato di pubblicazione: | Pubblicato | |
Data di pubblicazione: | feb-2009 | |
Titolo: | CYP4F2 genetic variant (rs2108622) significantly contributes to warfarin dosing variability in the Italian population | |
Autori: | ||
Autori: | Borgiani, P; Ciccacci, C; Forte, V; Sirianni, E; Novelli, L; Bramanti, P; Novelli, G | |
Appare nelle tipologie: | 01 - Articolo su rivista |